WELL Health Technologies Corp. (W7V.F)
| Previous close | 3.1840 |
| Open | 3.1420 |
| Bid | 3.2450 x 0 |
| Ask | 3.3950 x 0 |
| Day's range | 3.1420 - 3.1420 |
| 52-week range | 1.7590 - 3.9030 |
| Volume | |
| Avg. volume | 1,287 |
| Market cap | 750.187M |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | 0.0000 |
| Earnings date | 09 May 2023 - 15 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
WELL Health to Participate at Laurentian Bank Securities and Bloom Burton Conferences
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that a team from WELL Health including Hamed Shahbazi, Founder and CEO, will be participating in the Laurentian Bank Securities ("LBS") Diversified Virtual Technology Conference and the Bloom Burton & Co. Healthcare Investor Conference.
- PR Newswire
WELL Health Reports Record Revenue Results for Q4 and Full Year 2022 and Provides Strong Growth Outlook for 2023
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its audited consolidated financial results for the fiscal year and fourth quarter ended December 31, 2022.
- PR Newswire
WELL Health to Announce Fourth Quarter and Year End 2022 Financial Results on March 21, 2023
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the Company will release its Fiscal Fourth Quarter and Year End 2022 financial results for the period ended December 30, 2022, on Tuesday, March 21, 2023. The Company will hold a conference call and simultaneous webcast to discus
